Is the FDA Pausing More Cancer Trials? It's Hard to Tell
In October, the US Food and Drug Administration (FDA) pressed pause on a trial studying a new lymphoma drug after a patient died. A few months later, in December, the FDA made a similar move, temporarily halting a drug trial in non–small cell lung cancer …